Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-090848
Filing Date
2024-08-05
Accepted
2024-08-05 16:36:25
Documents
16
Effectiveness Date
2024-08-05

Document Format Files

Seq Description Document Type Size
1 S-8 axsm-20240805.htm S-8 91377
2 EX-5.1 axsm-ex5_1.htm EX-5.1 10592
3 EX-23.2 axsm-ex23_2.htm EX-23.2 3581
4 EX-23.3 axsm-ex23_3.htm EX-23.3 2875
5 EX-FILING FEES axsm_exfilingfees.htm   iXBRL EX-FILING FEES 33609
  Complete submission text file 0000950170-24-090848.txt   284043

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT axsm_exfilingfees_htm.xml XML 11135
Mailing Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

EIN.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-281249 | Film No.: 241175358
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)